OCT 12, 2026 · JOURNAL ARTICLE
ARF6: Biomarker, Therapeutic Target, and AI-Driven Precision Management for Type 2 Diabetes with Obesity
Metabolites
Type 2 diabetes combined with obesity is a prevalent metabolic comorbidity with high clinical heterogeneity, leading to inconsistent treatment efficacy and difficult long-term stan